{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:39:49Z","timestamp":1761896389544},"reference-count":58,"publisher":"The Japanese Society for Medical Mycology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3314\/mmj.16.001","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T22:17:39Z","timestamp":1472595459000},"page":"J103-J112","source":"Crossref","is-referenced-by-count":8,"title":["The Current Status of Drug-resistant &lt;I&gt;Aspergillus&lt;\/I&gt;"],"prefix":"10.3314","volume":"57","author":[{"given":"Masato","family":"Tashiro","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences"},{"name":"Nagasaki University Infection Control and Education Center, Nagasaki University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Izumikawa","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences"},{"name":"Nagasaki University Infection Control and Education Center, Nagasaki University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Patterson KC, Strek ME: Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest 146: 1358-1368, 2014.","DOI":"10.1378\/chest.14-0917"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Kosmidis C, Denning DW: The clinical spectrum of pulmonary aspergillosis. Thorax 70: 270-277, 2015.","DOI":"10.1136\/thoraxjnl-2014-206291"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB, Kibbler CC, Denning DW: British Society for Medical M. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis 15: 461- 474, 2015.","DOI":"10.1016\/S1473-3099(15)70006-X"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, Ullmann AJ, Dimopoulos G, Lange C: Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management. Eur Respir J 47: 45-68, 2016.","DOI":"10.1183\/13993003.00583-2015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46: 327-360, 2008.","DOI":"10.1086\/525258"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Izumikawa K, Tashiro M, Kohno S: Management of chronic pulmonary aspergillosis. Ann N Y Acad Sci 1272: 40-48, 2012.","DOI":"10.1111\/j.1749-6632.2012.06758.x"},{"key":"7","unstructured":"8) Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. 2nd ed. Approved standard M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008."},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Subcommittee on Antifungal Susceptibility Testing of the ESCMID : EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 14: 982-984, 2008.","DOI":"10.1111\/j.1469-0691.2008.02086.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, Denning DW: Azole antifungal resistance in <I>Aspergillus fumigatus<\/I>: 2008 and 2009. J Antimicrob Chemother 65: 2116-2118, 2010.","DOI":"10.1093\/jac\/dkq279"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Verweij PE, Ananda-Rajah M, Andes D, et al: International expert opinion on the management of infection caused by azole-resistant <I>Aspergillus fumigatus<\/I>. Drug Resist Updat 21-22: 30-40, 2015.","DOI":"10.1016\/j.drup.2015.08.001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS, Denning DW: Frequency and evolution of Azole resistance in <I>Aspergillus fumigatus<\/I> associated with treatment failure. Emerg Infect Dis 15: 1068-1076, 2009.","DOI":"10.3201\/eid1507.090043"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Lazzarini C, Esposto MC, Prigitano A, Cogliati M, De Lorenzis G, Tortorano AM: Azole Resistance in <I>Aspergillus fumigatus<\/I> Clinical Isolates from an Italian Culture Collection. Antimicrob Agents Chemother 60: 682-685, 2015.","DOI":"10.1128\/AAC.02234-15"},{"key":"13","unstructured":"14) European Committee on Antimicrobial Susceptibility Testing: Antifungal Agents Breakpoint tables for interpretation of MICs version 8.0, valid from 2015-11-16 http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Clinical_breakpoints\/Antifungal_breakpoints_v_8.0_November_2015.pdf 2015."},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Espinel-Ingroff A, Diekema DJ, Fothergill A, Johnson E, Pelaez T, Pfaller MA, Rinaldi MG, Canton E, Turnidge J: Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six <I>Aspergillus<\/I> spp. for the CLSI broth microdilution method (M38-A2 document). J Clin Microbiol 48: 3251-3257, 2010.","DOI":"10.1128\/JCM.00536-10"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M: Epidemiological cutoffs and cross-resistance to azole drugs in <I>Aspergillus fumigatus<\/I>. Antimicrob Agents Chemother 52: 2468-2472, 2008.","DOI":"10.1128\/AAC.00156-08"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Pfaller M, Boyken L, Hollis R, Kroeger J, Messer S, Tendolkar S, Diekema D: Use of epidemiological cutoff values to examine 9-year trends in susceptibility of <I>Aspergillus<\/I> species to the triazoles. J Clin Microbiol 49: 586-590, 2011.","DOI":"10.1128\/JCM.02136-10"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Pfaller MA, Diekema DJ, Ghannoum MA, et al: Wild-type MIC distribution and epidemiological cutoff values for <I>Aspergillus fumigatus<\/I> and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol 47: 3142-3146, 2009.","DOI":"10.1128\/JCM.00940-09"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Tashiro T, Izumikawa K, Tashiro M, Takazono T, Morinaga Y, Yamamoto K, Imamura Y, Miyazaki T, Seki M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Kohno S: Diagnostic significance of <I>Aspergillus<\/I> species isolated from respiratory samples in an adult pneumology ward. Med Mycol 49: 581-587, 2011.","DOI":"10.3109\/13693786.2010.548084"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Denning DW, Venkateswarlu K, Oakley KL, Anderson MJ, Manning NJ, Stevens DA, Warnock DW, Kelly SL: Itraconazole resistance in <I>Aspergillus fumigatus<\/I>. Antimicrob Agents Chemother 41: 1364- 1368, 1997.","DOI":"10.1128\/AAC.41.6.1364"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21) Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE: Emergence of azole resistance in <I>Aspergillus fumigatus<\/I> and spread of a single resistance mechanism. PLoS Med 5: e219, 2008.","DOI":"10.1371\/journal.pmed.0050219"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Tashiro M, Izumikawa K, Minematsu A, et al: Antifungal susceptibilities of <I>Aspergillus fumigatus<\/I> clinical isolates obtained in Nagasaki, Japan. Antimicrob Agents Chemother 56: 584-587, 2012.","DOI":"10.1128\/AAC.05394-11"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Asano M, Kano R, Makimura K, Hasegawa A, Kamata H: Molecular typing and <I>in-vitro<\/I> activity of azoles against clinical isolates of <I>Aspergillus fumigatus<\/I> and <I>A. niger<\/I> in Japan. J Infect Chemother 17: 483-486, 2011.","DOI":"10.1007\/s10156-010-0202-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Lass-Fl&ouml;rl C, Alastruey-Izquierdo A, Cuenca-Estrella M, Perkhofer S, Rodriguez-Tudela JL: <I>In vitro<\/I> activities of various antifungal drugs against <I>Aspergillus terreus<\/I>: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother 53: 794-795, 2009.","DOI":"10.1128\/AAC.00335-08"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25) Arendrup MC, Cuenca-Estrella M, Lass-Fl&ouml;rl C, Hope WW: Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against <I>Aspergillus<\/I> spp. Drug Resist Updat 16: 81-95, 2013.","DOI":"10.1016\/j.drup.2014.01.001"},{"key":"25","doi-asserted-by":"crossref","unstructured":"28) Rajendran R, Mowat E, McCulloch E, Lappin DF, Jones B, Lang S, Majithiya JB, Warn P, Williams C, Ramage G: Azole resistance of <I>Aspergillus fumigatus<\/I> biofilms is partly associated with efflux pump activity. Antimicrob Agents Chemother 55: 2092- 2097, 2011.","DOI":"10.1128\/AAC.01189-10"},{"key":"26","doi-asserted-by":"crossref","unstructured":"29) Alcazar-Fuoli L, Mellado E, Cuenca-Estrella M, Sanglard D: Probing the role of point mutations in the <I>cyp51A<\/I> gene from <I>Aspergillus fumigatus<\/I> in the model yeast Saccharomyces cerevisiae. Med Mycol 49: 276-284, 2011.","DOI":"10.3109\/13693786.2010.512926"},{"key":"27","doi-asserted-by":"crossref","unstructured":"30) Slaven JW, Anderson MJ, Sanglard D, Dixon GK, Bille J, Roberts IS, Denning DW: Increased expression of a novel <I>Aspergillus fumigatus<\/I> ABC transporter gene, atrF, in the presence of itraconazole in an itraconazole resistant clinical isolate. Fungal Genet Biol 36: 199-206, 2002.","DOI":"10.1016\/S1087-1845(02)00016-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"31) Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJ: Azole resistance profile of amino acid changes in <I>Aspergillus fumigatus<\/I> CYP51A based on protein homology modeling. Antimicrob Agents Chemother 54: 2425-2430, 2010.","DOI":"10.1128\/AAC.01599-09"},{"key":"29","doi-asserted-by":"crossref","unstructured":"32) Liu M, Zheng N, Li D, Zheng H, Zhang L, Ge H, Liu W: cyp51A-based mechanism of azole resistance in <I>Aspergillus fumigatus<\/I>: Illustration by a new 3D Structural Model of <I>Aspergillus fumigatus<\/I> CYP51A protein. Med Mycol 54: 400-408, 2016.","DOI":"10.1093\/mmy\/myv102"},{"key":"30","doi-asserted-by":"crossref","unstructured":"33) Verweij PE, Chowdhary A, Melchers WJ, Meis JF: Azole resistance in <I>Aspergillus fumigatus<\/I>: can we retain the clinical use of mold-active antifungal azoles? Clin Infect Dis 62: 362-368, 2016.","DOI":"10.1093\/cid\/civ885"},{"key":"31","doi-asserted-by":"crossref","unstructured":"35) Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ: Rapid induction of multiple resistance mechanisms in <I>Aspergillus fumigatus<\/I> during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother 56: 10-16, 2011.","DOI":"10.1128\/AAC.05088-11"},{"key":"32","doi-asserted-by":"crossref","unstructured":"36) Arendrup MC, Mavridou E, Mortensen KL, Snelders E, Frimodt-M&oslash;ller N, Khan H, Melchers WJ, Verweij PE: Development of azole resistance in <I>Aspergillus fumigatus<\/I> during azole therapy associated with change in virulence. PLoS ONE 5: e10080, 2010.","DOI":"10.1371\/journal.pone.0010080"},{"key":"33","doi-asserted-by":"crossref","unstructured":"37) Bellete B, Raberin H, Morel J, Flori P, Hafid J, Manhsung RT: Acquired resistance to voriconazole and itraconazole in a patient with pulmonary aspergilloma. Med Mycol 48: 197-200, 2010.","DOI":"10.3109\/13693780902717018"},{"key":"34","doi-asserted-by":"crossref","unstructured":"38) Tashiro M, Izumikawa K, Hirano K, et al: Correlation between triazole treatment history and susceptibility in clinically isolated <I>Aspergillus fumigatus<\/I>. Antimicrob Agents Chemother 56: 4870-4875, 2012.","DOI":"10.1128\/AAC.00514-12"},{"key":"35","doi-asserted-by":"crossref","unstructured":"39) Escribano P, Recio S, Pel&aacute;ez T, Gonz&aacute;lez-Rivera M, Bouza E, Guinea J: <I>In vitro<\/I> acquisition of secondary azole resistance in <I>Aspergillus fumigatus<\/I> isolates after prolonged exposure to itraconazole: presence of heteroresistant populations. Antimicrob Agents Chemother 56: 174-178, 2012.","DOI":"10.1128\/AAC.00301-11"},{"key":"36","doi-asserted-by":"crossref","unstructured":"40) Mortensen KL, Mellado E, Lass-Fl&ouml;rl C, Rodriguez-Tudela JL, Johansen HK, Arendrup MC: Environmental study of azole-resistant <I>Aspergillus fumigatus<\/I> and other <I>Aspergilli<\/I> in Austria, Denmark, and Spain. Antimicrob Agents Chemother 54: 4545-4549, 2010.","DOI":"10.1128\/AAC.00692-10"},{"key":"37","doi-asserted-by":"crossref","unstructured":"41) Verweij PE, Snelders E, Kema GH, Mellado E, Melchers WJ: Azole resistance in <I>Aspergillus fumigatus<\/I>: a side-effect of environmental fungicide use? Lancet Infect Dis 9: 789-795, 2009.","DOI":"10.1016\/S1473-3099(09)70265-8"},{"key":"38","doi-asserted-by":"crossref","unstructured":"42) Snelders E, Huis in&rsquo;t Veld RA, Rijs AJ, Kema GH, Melchers WJ, Verweij PE: Possible environmental origin of resistance of <I>Aspergillus fumigatus<\/I> to medical triazoles. Appl Environ Microbiol 75: 4053-4057, 2009.","DOI":"10.1128\/AEM.00231-09"},{"key":"39","doi-asserted-by":"crossref","unstructured":"43) Kano R, Kohata E, Tateishi A, Murayama SY, Hirose D, Shibata Y, Kosuge Y, Inoue H, Kamata H, Hasegawa A: Does farm fungicide use induce azole resistance in <I>Aspergillus fumigatus<\/I>? Med Mycol 53: 174-177, 2015.","DOI":"10.1093\/mmy\/myu076"},{"key":"40","doi-asserted-by":"crossref","unstructured":"45) Chowdhary A, Kathuria S, Randhawa HS, Gaur SN, Klaassen CH, Meis JF: Isolation of multiple-triazole-resistant <I>Aspergillus fumigatus<\/I> strains carrying the TR\/L98H mutations in the <I>cyp51A<\/I> gene in India. J Antimicrob Chemother 67: 362-366, 2012.","DOI":"10.1093\/jac\/dkr443"},{"key":"41","doi-asserted-by":"crossref","unstructured":"46) van der Linden JW, Arendrup MC, Warris A, et al: Prospective multicenter international surveillance of azole resistance in <I>Aspergillus fumigatus<\/I>. Emerg Infect Dis 21: 1041-1044, 2015.","DOI":"10.3201\/eid2106.140717"},{"key":"42","doi-asserted-by":"crossref","unstructured":"47) Thors VS, Bierings MB, Melchers WJ, Verweij PE, Wolfs TF: Pulmonary aspergillosis caused by a pan-azole-resistant <I>Aspergillus fumigatus<\/I> in a 10-year-old boy. Pediatr Infect Dis J 30: 268-270, 2011.","DOI":"10.1097\/INF.0b013e3182037879"},{"key":"43","doi-asserted-by":"crossref","unstructured":"48) Mortensen KL, Jensen RH, Johansen HK, Skov M, Pressler T, Howard SJ, Leatherbarrow H, Mellado E, Arendrup MC: <I>Aspergillus<\/I> species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on <I>Aspergillus fumigatus<\/I> azole resistance. J Clin Microbiol 49: 2243-2251, 2011.","DOI":"10.1128\/JCM.00213-11"},{"key":"44","doi-asserted-by":"crossref","unstructured":"49) Mortensen KL, Johansen HK, Fuursted K, Knudsen JD, Gahrn-Hansen B, Jensen RH, Howard SJ, Arendrup MC: A prospective survey of <I>Aspergillus<\/I> spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. Eur J Clin Microbiol Infect Dis 30: 1355-1363, 2011.","DOI":"10.1007\/s10096-011-1229-7"},{"key":"45","doi-asserted-by":"crossref","unstructured":"50) Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ, Balajee SA: Azole resistance in <I>Aspergillus fumigatus<\/I> isolates from the ARTEMIS global surveillance is primarily due to the TR\/L98H mutation in the <I>cyp51A<\/I> gene. Antimicrob Agents Chemother 55: 4465-4468, 2011.","DOI":"10.1128\/AAC.00185-11"},{"key":"46","doi-asserted-by":"crossref","unstructured":"51) Arabatzis M, Kambouris M, Kyprianou M, et al: Polyphasic identification and susceptibility to seven antifungals of 102 <I>Aspergillus<\/I> isolates recovered from immunocompromised hosts in Greece. Antimicrob Agents Chemother 55: 3025-3030, 2011.","DOI":"10.1128\/AAC.01491-10"},{"key":"47","doi-asserted-by":"crossref","unstructured":"52) Brillowska-Dabrowska A, Mroczy&nacute;ska M, Nawrot U, Wlodarczyk K, Kurzyk E: Examination of cyp51A and cyp51B expression level of the first Polish azole resistant clinical <I>Aspergillus fumigatus<\/I> isolate. Acta Biochim Pol 62: 837-839, 2015.","DOI":"10.18388\/abp.2015_1143"},{"key":"48","doi-asserted-by":"crossref","unstructured":"53) Wu CJ, Wang HC, Lee JC, Lo HJ, Dai CT, Chou PH, Ko WC, Chen YC: Azole-resistant <I>Aspergillus fumigatus<\/I> isolates carrying TR<sub>34<\/sub>\/L98H mutations in Taiwan. Mycoses 58: 544-549, 2015.","DOI":"10.1111\/myc.12354"},{"key":"49","doi-asserted-by":"crossref","unstructured":"54) Kidd SE, Goeman E, Meis JF, Slavin MA, Verweij PE: Multi-triazole-resistant <I>Aspergillus fumigatus<\/I> infections in Australia. Mycoses 58: 350-355, 2015.","DOI":"10.1111\/myc.12324"},{"key":"50","doi-asserted-by":"crossref","unstructured":"55) &Ouml;zmerdiven GE, Ak S, Ener B, Agca H, Cilo BD, Tunca B, Akalin H: First determination of azole resistance in <I>Aspergillus fumigatus<\/I> strains carrying the TR34\/L98H mutations in Turkey. J Infect Chemother 21: 581-586, 2015.","DOI":"10.1016\/j.jiac.2015.04.012"},{"key":"51","doi-asserted-by":"crossref","unstructured":"56) Liu M, Zeng R, Zhang L, Li D, Lv G, Shen Y, Zheng H, Zhang Q, Zhao J, Zheng N, Liu W: Multiple cyp51A-based mechanisms identified in azole-resistant isolates of <I>Aspergillus fumigatus<\/I> from China. Antimicrob Agents Chemother 59: 4321-4325, 2015.","DOI":"10.1128\/AAC.00003-15"},{"key":"52","doi-asserted-by":"crossref","unstructured":"57) Chowdhary A, Sharma C, van den Boom M, Yntema JB, Hagen F, Verweij PE, Meis JF: Multi-azole-resistant <I>Aspergillus fumigatus<\/I> in the environment in Tanzania. J Antimicrob Chemother 69: 2979-2983, 2014.","DOI":"10.1093\/jac\/dku259"},{"key":"53","doi-asserted-by":"crossref","unstructured":"58) Ahmad S, Khan Z, Hagen F, Meis JF: Occurrence of triazole-resistant <I>Aspergillus fumigatus<\/I> with TR34\/L98H mutations in outdoor and hospital environment in Kuwait. Environ Res 133: 20-26, 2014.","DOI":"10.1016\/j.envres.2014.05.009"},{"key":"54","doi-asserted-by":"crossref","unstructured":"59) Badali H, Vaezi A, Haghani I, Yazdanparast SA, Hedayati MT, Mousavi B, Ansari S, Hagen F, Meis JF, Chowdhary A: Environmental study of azole-resistant <I>Aspergillus fumigatus<\/I> with TR34\/L98H mutations in the cyp51A gene in Iran. Mycoses 56: 659-663, 2013.","DOI":"10.1111\/myc.12089"},{"key":"55","doi-asserted-by":"crossref","unstructured":"60) Bader O, Weig M, Reichard U, Lugert R, Kuhns M, Christner M, Held J, Peter S, Schumacher U, Buchheidt D, Tintelnot K, Gro&szlig; U: cyp51A-Based mechanisms of <I>Aspergillus fumigatus<\/I> azole drug resistance present in clinical samples from Germany. Antimicrob Agents Chemother 57: 3513-3517, 2013.","DOI":"10.1128\/AAC.00167-13"},{"key":"56","doi-asserted-by":"crossref","unstructured":"61) Wiederhold NP, Gil VG, Gutierrez F, Lindner JR, Albataineh MT, McCarthy DI, Sanders C, Fan H, Fothergill AW, Sutton DA: First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in <I>Aspergillus fumigatus<\/I> Isolates in the United States. J Clin Microbiol 54: 168-171, 2016.","DOI":"10.1128\/JCM.02478-15"},{"key":"57","doi-asserted-by":"crossref","unstructured":"62) Fuhren J, Voskuil WS, Boel CH, Haas PJ, Hagen F, Meis JF, Kusters JG: High prevalence of azole resistance in <I>Aspergillus fumigatus<\/I> isolates from high-risk patients. J Antimicrob Chemother 70: 2894-2898, 2015.","DOI":"10.1093\/jac\/dkv177"},{"key":"58","doi-asserted-by":"crossref","unstructured":"63) Abdolrasouli A, Rhodes J, Beale MA, Hagen F, Rogers TR, Chowdhary A, Meis JF, Armstrong-James D, Fisher MC: Genomic Context of Azole Resistance Mutations in <I>Aspergillus fumigatus<\/I> Determined Using Whole-Genome Sequencing. MBio 6: e00536, 2015.","DOI":"10.1128\/mBio.00939-15"}],"container-title":["Medical Mycology Journal"],"original-title":["\u85ac\u5264\u8010\u6027\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u306e\u73fe\u72b6"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/57\/3\/57_16.001\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T02:41:42Z","timestamp":1568342502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/57\/3\/57_16.001\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.16.001","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}